SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-031932
Filing Date
2018-05-10
Accepted
2018-05-10 07:04:10
Documents
3
Period of Report
2018-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-13130_18k.htm 8-K 23384
2 EX-99.1 a18-13130_1ex99d1.htm EX-99.1 285514
3 GRAPHIC g131301mm01i001.jpg GRAPHIC 3865
  Complete submission text file 0001104659-18-031932.txt   315597
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 18820454
SIC: 2834 Pharmaceutical Preparations